4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-007764
President and CEO sold 8,828 shares at $9.86 ($87,009)
- President and CEO acquired 180,565 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Touchon Pascal President and CEO | 2022-03-01 | Grant or award | +180,565 | 509,054 | D | ||
| Touchon Pascal President and CEO | 2022-03-01 | Sale | −8,828 | $9.86 | $87,009 | 500,226 | D |
| Derivatives | |||||||
| Touchon Pascal President and CEO | 2022-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +339,419 | 339,419 | D | ||
| Open-market sales · 8,828 sh · avg $9.86 · $87,009 | |||||||
Loading xslF345X03/form4.xml…